Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
343.9 USD | +0.49% | -5.32% | -4.82% |
29/04 | Wells Fargo Adjusts Price Target on Molina Healthcare to $375 From $410 | MT |
26/04 | Jefferies Adjusts Price Target on Molina Healthcare to $354 From $393 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.43 for the 2024 fiscal year.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.82% | 20.05B | B- | ||
-7.11% | 456B | B- | ||
+13.24% | 125B | A- | ||
+19.03% | 101B | B- | ||
-0.51% | 39.69B | B- | ||
-33.78% | 36.86B | A- | ||
-12.48% | 3.08B | C+ | ||
-41.00% | 993M | B- | ||
-29.20% | 337M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MOH Stock
- Ratings Molina Healthcare, Inc.